HBV Community Forum at the 2022 International HBV Meeting – ICE-HBV

HBV Community Forum at the 2022 International HBV Meeting

by

When & Where:

Thursday, 22 September 2022 8am-9:30am CET (TBC)
Novotel Paris Centre Tour Eiffel, France & Online
(the recording will be made available online after the event)

Tentative Program:

Welcome and update on Hepatitis B epidemiology in Europe
Fabien Zoulim ( Lyon University, Lyon, France)
Hepatitis B 101 & Update on cure research
Thomas Tu (University of Sydney / HepBCommunity.org, Sydney, Australia) & John Tavis (Saint Louis University School of Medicine / ICE-HBV, Saint Louis, MO, United States)
Panel Discussion: Critical gaps in hepatitis B prevention, screening, care and treatment in the EU
Marc Bourlière (Hôpital Saint Joseph, Marseille, France), Tarik Asselah (Hôpital Beaujon, and University Paris Diderot, Paris, France), Philippa Matthews (The Francis Crick Institute / University College London, UK)
Patient panel: Living with Hepatitis B
Closing remarks
Chari Cohen (Hepatitis B Foundation, Doylestown, PA, United States)

Download event flyer here.

Co-organized by:

To register for this event please visit the following URL: https://www.hbvmeeting.org/program/hbv-patient-forum/ →

Date And Time

September 22, 2022 to
September 22, 2022

Location

Online event

Event Types

Event Category

Share With Friends

An Optimized Ex Vivo ELISpot assay to identify IFN gamma positive, HBV-specific T cells in Chronic Hepatitis B patients

During a traditional ELISpot assay, low HBV Specific T cell frequencies have hinde... [Read more]

12 April, 2023
Multiplexed immunostaining of formalin-fixed paraffin-embedded liver biopsy tissues with metal-conjugated antibodies for tissue imaging mass cytometry

This protocol describes the approach used to stain formalin-fixed paraffin-embedded liver biopsy slides with a ... [Read more]

12 April, 2023
A modified kit-based HBV protein-free DNA extraction from liver tissues and cell cultures for HBV cccDNA Southern blot and qPCR
- cccDNA quantification from total DNA preparation by qPCR with cccDNA-selective primers is challengi... [Read more]
21 September, 2022
A sensitive and rapid Southern blot assay based on branched DNA technology for the detection of HBV DNA in cell culture and liver tissue samples
- Sothern blot is considered the “gold standard” for cccDNA detection because it can separate the ccc... [Read more]
21 September, 2022
An Optimized Ex Vivo Flurospot assay to identify multi-functional HBV-specific T cells in Chronic Hepatitis B patients

During a traditional FluroSpot assay, low HBV Specific T cell frequencies have hindered effective ex vivo analy... [Read more]

07 March, 2022
Fluorescent-bait labelling for the ex vivo detection of HBV antigen-specific B cells

Fluorescently conjugated antigen-bait systems have been extensively used to identify antigen-specific B cells a... [Read more]

30 April, 2021
Tetramer enrichment for HBV-specific CD8+ T cells

The frequency of HBV-specific CD8+ T cells can be very low, depending on the specificity. Therefore, they canno... [Read more]

03 July, 2020
A fluorescent in situ hybridization (FISH) assay for detection of HBV DNA in cell culture models
- Although a plethora of knowledge on the molecular life cycle of Hepatitis B Virus has been gained b... [Read more]
19 June, 2020
HBV Ribonuclease H assay resolved by denaturing PAGE
- This assay characterizes the products of HBV RNase H activity on a DNA:RNA heteroduplex.
- Products are resolved by denaturing PAGE to assess specificity of cleavage and effects of inhibitory compounds on the enzyme
06 June, 2019
HBV Ribonuclease H FRET Assay
- This assay detects the activity of HBV RNaseH using fluorescence resonance energy transfer
06 June, 2019